Clinical trial
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of…
NCT00002735 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00002735 |
|---|---|
| Title | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue |
| Official title | Induction Chemotherapy Followed By Chemoradiation For Organ Preservation In Patients With Advanced Resectable Cancer Of The Hypopharynx And Base Of Tongue, Phase II |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Induction chemotherapy, cisplatin, fluorouracil, low-LET cobalt-60 gamma ray therapy |
| Enrollment | 68 |
| Start date | Apr 1, 1996 |
| Primary completion | Apr 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Sep 1, 2004 |
| Last update posted | Sep 30, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: